Pharma Journalist -

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to…
Read More...

Nabriva Therapeutics plc announced that the U.S. Food and Drug Administration (FDA) has approved Nabriva’s new drug applications for the oral and intravenous (IV) formulations of…
Read More...

Mateon Therapeutics and PointR Data announced that they have entered into a definitive agreement with respect to a merger, creating a publicly traded artificial intelligence (“AI”)…
Read More...

Sarepta Therapeutics announced it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) seeking…
Read More...

EAG Laboratories proudly announces the launch of a new laboratory in China dedicated to improving materials, products and electronics. Newly built in Shanghai, this facility brings the…
Read More...

Gilead Sciences, Inc. and Galapagos NV announced that the Marketing Authorization Application (MAA) for filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has approved Rozlytrek™ (entrectinib) for the treatment of adults with ROS1-positive,…
Read More...

Harmony Biosciences, LLC (Harmony) announced that the U.S. Food and Drug Administration (FDA) approved WAKIX (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in…
Read More...

SMi Reports: Registration is open for SMi Group’s 12th annual conference and exhibition taking place in January 2020 in London. As Europe’s leading Pre-Filled Syringes conference,…
Read More...